» Articles » PMID: 35918597

Bariatric Surgery Conversions in MBSAQIP Centers: Current Indications and Outcomes

Overview
Journal Obes Surg
Date 2022 Aug 2
PMID 35918597
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The demand for revisional bariatric surgery has increased, and bariatric conversions (BC) to a different procedure represent most of the revisional cases. The 2020 Metabolic and Bariatric Surgery Accreditfnation and Quality Improvement Program (MBSAQIP) database was expanded to include additional variables on BC. This study aims to analyze the indications and outcomes of BC.

Methods: A retrospective analysis of the 2020 MBSAQIP database was performed. Patients who underwent BC were included in the analysis. Index procedures, rates, and indications for BC of the different bariatric operations were described. Outcomes of the most frequent BC were analyzed.

Results: A total of 168,548 bariatric surgeries were done; 20,387 (12.1%) were revisional, and from those 15,031 (73.7%) were BC. The most converted index operations were sleeve gastrectomy (SG) (49.3%) and adjustable gastric banding (AGB) (45.9%). The most frequent conversions were SG to Roux-en-Y gastric bypass (RYGB) (40.3%) for gastroesophageal reflux disease (GERD) (54.2%) and weight loss failure (WLF) (35.8%), AGB to SG (27%) or RYGB (16.2%) for WLF (67% and 61.3%, respectively), and SG to biliopancreatic diversion with duodenal switch (3.2%) or single anastomosis duodeno-ileal bypass (2%) for WLF (91.2% and 92.4%, respectively). Postoperative overall morbidity, serious morbidity, reoperation, and mortality rates ranged from 5.3 to 20.8%, 2.3 to 19.2%, 1.5 to 10%, and 0 to 0.8%, respectively.

Conclusions: BC represents the most frequent revisional bariatric procedure. GERD and WLF are the main causes for BC. Further research is needed to define the ideal BC according to the index procedure and indication.

Citing Articles

Experiencing Complications After Metabolic and Bariatric Surgeries is a Risk Factor for Postoperative Emergency Department Admissions: a Retrospective Cohort Study.

Toprak S, Toprak H, Kose F Obes Surg. 2025; 35(3):875-883.

PMID: 39891838 PMC: 11906519. DOI: 10.1007/s11695-025-07710-1.


Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS).

De Luca M, Shikora S, Eisenberg D, Angrisani L, Parmar C, Alqahtani A Obes Surg. 2024; 34(11):3963-4096.

PMID: 39320627 PMC: 11541402. DOI: 10.1007/s11695-024-07370-7.


Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy/Single Anastomosis Duodenal Switch (SADI-S/SADS) IFSO Position Statement-Update 2023.

Ponce de Leon-Ballesteros G, Romero-Velez G, Higa K, Himpens J, O Kane M, Torres A Obes Surg. 2024; 34(10):3639-3685.

PMID: 39264553 DOI: 10.1007/s11695-024-07490-0.


Metabolic and Bariatric Surgeon Criteria-An International Experts' Consensus.

Kermansaravi M, Chiappetta S, Shikora S, Musella M, Kow L, Aarts E Obes Surg. 2024; 34(9):3216-3228.

PMID: 39046625 DOI: 10.1007/s11695-024-07395-y.


Bariatric surgery: trends in utilization, complications, conversions and revisions.

Hsu J, Ismail S, Hodges M, Agala C, Farrell T Surg Endosc. 2024; 38(8):4613-4623.

PMID: 38902405 PMC: 11289040. DOI: 10.1007/s00464-024-10985-7.